Solid-State NMR Characterization of Phenylbenzimidazolesulfonic Acid Coencapsulated with Cetyltrimethylammonium in Mesoporous Silica Materials

被引:6
作者
Bongur, Raphael [1 ]
Marx, Nicolas [1 ]
Marichal, Claire [1 ]
Lebeau, Benedicte [1 ]
Guarilloff, Philippe [2 ]
机构
[1] Univ Haute Alsace, ENSCMu, LRC CNRS 7228, Equipe Mat Porosite Controlee,Inst Sci Mat Mulhou, F-68093 Mulhouse, France
[2] Chanel PB Lab, Piscataway, NJ 08855 USA
关键词
MCM-41-TYPE MOLECULAR-SIEVES; PHTHALOCYANINE COMPLEXES; PORE DISTRIBUTIONS; CYLINDRICAL PORES; SULFONIC-ACID; STABILITY; SYSTEMS; ENCAPSULATION; ADSORPTION; INCLUSION;
D O I
10.1021/jp907051f
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
The hydrophilic Molecule phenylbenzimidazolesulfonic acid (PBSA) has been coencapsulated with cetyltrimethylammonium chloride (CTAC), an amphiphilic surfactant, via all in Situ method in a mesoporous Silica matrix. The effect of coencapsulation on texture and structure of the mesoporous silica host has been Studied by X-ray diffraction (XRD), transmission electron microscopy (TEM), nitrogen sorption experiments, and Si-29 magic-angle spinning (MAS) NMR spectroscopy. It was clearly observed that the presence of PBSA led to different characteristics compared to the reference MCM-41 type organized mesoporous Silica (OMS), which suggests that the active molecules perturb the silica network formation. The encapsulation of the hydrophilic PBSA molecule was found to be stable in aqueous media, indicating that strong interactions exist between PBSA and its environment (surfactant and silica framework). H-1-Si-29 and H-1-C-13 MAS NMR experiments evidenced their spatial proximity and confirmed the presence of interaction between PBSA and both CTA(+) molecules and silanol of the silica framework. This NMR Study gave an overall Picture of the organic/inorganic interface.
引用
收藏
页码:752 / 759
页数:8
相关论文
共 46 条
[1]   Solid-state NMR study of ibuprofen confined in MCM-41 material [J].
Azais, Thierry ;
Tourne-Peteilh, Corine ;
Aussenac, Fabien ;
Baccile, Niki ;
Coelho, Cristina ;
Devoisselle, Jean-Marie ;
Babonneau, Florence .
CHEMISTRY OF MATERIALS, 2006, 18 (26) :6382-6390
[2]   Solid state NMR characterisation of encapsulated molecules in mesoporous silica [J].
Babonneau, F ;
Yeung, L ;
Steunou, N ;
Gervais, C ;
Ramila, A ;
Vallet-Regi, M .
JOURNAL OF SOL-GEL SCIENCE AND TECHNOLOGY, 2004, 31 (1-3) :219-223
[3]   THE DETERMINATION OF PORE VOLUME AND AREA DISTRIBUTIONS IN POROUS SUBSTANCES .1. COMPUTATIONS FROM NITROGEN ISOTHERMS [J].
BARRETT, EP ;
JOYNER, LG ;
HALENDA, PP .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1951, 73 (01) :373-380
[4]   A NEW FAMILY OF MESOPOROUS MOLECULAR-SIEVES PREPARED WITH LIQUID-CRYSTAL TEMPLATES [J].
BECK, JS ;
VARTULI, JC ;
ROTH, WJ ;
LEONOWICZ, ME ;
KRESGE, CT ;
SCHMITT, KD ;
CHU, CTW ;
OLSON, DH ;
SHEPPARD, EW ;
MCCULLEN, SB ;
HIGGINS, JB ;
SCHLENKER, JL .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1992, 114 (27) :10834-10843
[5]   Synthesis and electron spin resonance studies of MCM-41 doped with copper pyridine complexes [J].
Bohlmann, W ;
Schandert, K ;
Poppl, A ;
Semmelhack, HC .
ZEOLITES, 1997, 19 (04) :297-304
[6]  
BRAUCHLE C, 1991, STUDIES SURFACE SCI, V69
[7]   STUDIES ON PORE SYSTEMS IN CATALYSTS .13. PORE DISTRIBUTIONS FROM DESORPTION BRANCH OF A NITROGEN SORPTION ISOTHERM IN CASE OF CYLINDRICAL PORES .B. APPLICATIONS [J].
BROEKHOFF, JC ;
DEBOER, JH .
JOURNAL OF CATALYSIS, 1968, 10 (04) :377-+
[8]   STUDIES ON PORE SYSTEMS IN CATALYSTS .X. CALCULATIONS OF PORE DISTRIBUTIONS FROM ADSORPTION BRANCH OF NITROGEN SORPTION ISOTHERMS IN CASE OF OPEN CYLINDRICAL PORES .B. APPLICATIONS [J].
BROEKHOFF, JC ;
DEBOER, JH .
JOURNAL OF CATALYSIS, 1967, 9 (01) :15-+
[9]   Adsorption of gases in multimolecular layers [J].
Brunauer, S ;
Emmett, PH ;
Teller, E .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1938, 60 :309-319
[10]   Inclusion of ibuprofen in mesoporous templated silica:: drug loading and release property [J].
Charnay, C ;
Bégu, S ;
Tourné-Péteilh, C ;
Nicole, L ;
Lerner, DA ;
Devoisselle, JM .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2004, 57 (03) :533-540